《新股消息》美皓集團(01947.HK)每股下限定價0.84元 一手中籤率僅6.14%
溫州私人牙科服務提供商美皓集團(01947.HK)公布招股結果,擬全球發售1.5億股,原計劃香港公開發售佔一成,香港公開發售部分錄得超額認購約40.31倍,將3,000萬股國際配售股份從國際配售重新分配至香港公開發售。而國際配售項下初步提呈發售股份已獲適度超額認購。
每股發售價定為0.84元,為招股價範圍(0.84至1元)下限定價,每手5,000股計,一手中籤率僅6.14%,要認購30手(即15萬股)才穩獲一手。該股將於明日(14日)掛牌。聯席保薦人為創陞融資及國金證券(香港)。
公司上市料淨集資約7,490萬元,當中約28.6%將用於潛在策略性收購中國兩家牙科醫院;約27%用於撥付溫州口腔發展的資本支出及初始經營成本;約14.1%用於撥付在溫州建立鹿城兒童醫院的資本支出及初始經營成本;約10%用於營運資金及其他一般公司用途;約8.6%用於撥付在溫州以外地區以新商標名成立連鎖牙科診所的資本支出及初始經營成本;約5.4%用於設立牙科培訓中心;約3.3%用於購置新的牙科設備和耗材;及約3%用於翻新溫州醫院以擴充兒童牙科部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.